University at Buffalo Teams will seek to develop treatment options that could benefit patients with multiple sclerosis, hemophilia and more BUFFALO, N.Y. — Two University at Buffalo drug development and discovery projects have received investments from the Empire Discovery Institute. One project focuses on an immunotherapy platform — developed by UB pharmacy researcher Sathy Balu-Iyer and his team — that could benefit patients who are receiving gene therapy for a variety of diseases. The other will seek to design a therapy for multiple sclerosis (MS) that leverages a novel drug target discovered by a team led by UB medical researcher M. Laura Feltri.